The company
Mammotome is a pioneer in the field of vacuum-assisted breast biopsy and the company has celebrated 25 years of delivering innovations. It all began in 1995 with the Mammotome breast biopsy system. This technology transformed breast cancer interventions from open surgical biopsies to minimally invasive procedures. Since then, Mammotome employees globally have committed to the goal of providing clinics and their patients with better breast care. Behind this is their passion for developing innovative technology that facilitates better efficiency for radiologists and surgeons. At the same time, Mammotome never forgets that there is a patient at the heart of every breast cancer journey.
In 2014, Devicor Medical Products, Inc. (Mammotome) was acquired by Leica Biosystems and since that point have belonged to the Danaher Corporation. To date, more than 10 million women globally have undergone the minimally invasive Mammotome breast biopsy procedure. Mammotome’s EMEA headquarters are located in Quickborn, to the north of Hamburg, Germany.